Lori Elizabeth Dodd
National Institutes of Health · 160 works · 47,848 citations · h-index 40
Top works
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- Remdesivir for the Treatment of Covid-19 — Final Report
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): A Completed Reference Database of Lung Nodules on CT Scans
- Recommendations for the assessment of progression in randomised cancer treatment trials
- Lessons learned from independent central review
- Validation of novel imaging methodologies for use as cancer clinical trial end-points
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?
- Statistical considerations for a trial of Ebola virus disease therapeutics
- Partial AUC Estimation and Regression
- A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard
- Assessment methodologies and statistical issues for computer-aided diagnosis of lung nodules in computed tomography
- Semiparametric Regression for the Area Under the Receiver Operating Characteristic Curve
- Evaluation of Perceived Threat Differences Posed by Filovirus Variants
- Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
- Evaluating Imaging and Computer-aided Detection and Diagnosis Devices at the FDA
- Frequency, Severity, and Prediction of Tuberculous Meningitis Immune Reconstitution Inflammatory Syndrome
- Evaluation of Tuberculosis Diagnostics in Children: 2. Methodological Issues for Conducting and Reporting Research Evaluations of Tuberculosis Diagnostics for Intrathoracic Tuberculosis in Children. Consensus From an Expert Panela
- An Audit Strategy for Progression-Free Survival